Toripalimab (anti-PD-1) versus high-dose interferon-α2b as adjuvant therapy in resected mucosal melanoma: a phase II randomized trial

Bin Lian, Lu Si, Z.H. Chi, Xinan Sheng, Yan Kong, X. Wang, Hui Tian, Kejia Li, Li Mao, Xue Bai, B.X. Tang, Xieqiao Yan, S.M. Li, Li Zhou, Jie Dai, Xiongwen Tang, Fei-Wu Ran, Sheng Yao, Jun Guo, C. Cui